Skip to main content
OpenTrials

Clinical trial condition

Anemia, Refractory

Explore clinical trials studying Anemia, Refractory. Study availability and eligibility vary by location and protocol.

73 public trials 1 recruiting study
Refine in advanced search Browse all conditions

Anemia, Refractory trial results

Completed

Antithymocyte Globulin Compared With Supportive Care in Treating Patients With Myelodysplastic Syndrome

NCT00017550

Conditions
Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +4 more
Locations
  • Washington Cancer Institute Washington D.C., District of Columbia, United States
  • University of Florida Health Science Center Gainesville, Florida, United States
  • Sylvester Cancer Center, University of Miami Miami, Florida, United States
  • H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States
View all 28 locations
View Trial Details
Completed

Fludarabine Phosphate and Total Body Irradiation Followed by a Donor Peripheral Stem Cell Transplant in Treating Patients With Myelodysplastic Syndromes or Myeloproliferative Disorders

NCT00397813

Conditions
Anemia, Anemia, Hemolytic, Anemia, Refractory, +40 more
Locations
  • LDS Hospital Salt Lake City, Utah, United States
  • Veterans Administration Center-Seattle Seattle, Washington, United States
  • Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
View Trial Details
Completed

Mycophenolate Mofetil and Cyclosporine in Reducing Graft-Versus-Host Disease in Patients With Hematologic Malignancies or Metastatic Kidney Cancer Undergoing Donor Stem Cell Transplant

NCT00078858

Conditions
Accelerated Phase Chronic Myelogenous Leukemia, Adenocarcinoma, Adult Acute Lymphoblastic Leukemia in Remission, +220 more
Locations
  • Stanford University Hospitals and Clinics Stanford, California, United States
  • Rocky Mountain Cancer Centers-Midtown Denver, Colorado, United States
  • Emory University/Winship Cancer Institute Atlanta, Georgia, United States
  • OHSU Knight Cancer Institute Portland, Oregon, United States
View Trial Details
Completed

Total-Body Irradiation and Fludarabine Phosphate Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies or Kidney Cancer

NCT00027820

Conditions
Adenocarcinoma, Adult Acute Myeloid Leukemia in Remission, Anemia, +72 more
Locations
  • University of Arizona Health Sciences Center Tucson, Arizona, United States
  • Stanford University Hospitals and Clinics Stanford, California, United States
  • Emory University/Winship Cancer Institute Atlanta, Georgia, United States
  • OHSU Knight Cancer Institute Portland, Oregon, United States
View Trial Details
Completed

Laboratory-Treated Lymphocyte Infusion After Haploidentical Donor Stem Cell Transplant

NCT00376480

Conditions
Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +9 more
Locations
  • Childrens Hospital Los Angeles Los Angeles, California, United States
  • University of Florida Health Science Center - Gainesville Gainesville, Florida, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Children's Hospital Boston Boston, Massachusetts, United States
View Trial Details

Related conditions